The mysterious visage of Mona Lisa - one of
the main reasons why this magnificent 16th-century piece of art still reigns as
one of the most famous artworks in the world - shows signs that the model in
the oil painting suffered from xanthelasma, a subcutaneous accumulation of
cholesterol and a build-up of fatty acids just under the skin.
In
possibly the most unflattering diagnosis for one of history's most enchanting
beauties, Prof Vito Franco, a medical professor who also studies artworks, claimed
that he spotted clear signs of the condition in the hollow of Mona Lisa's left
eye, as well as evidence of a fatty tissue tumour (lipoma) on her right hand.
The
model is thought to be Lisa del Giocondo, a member of a Florence family, who
married a cloth and silk merchant.
Unfortunately,
at the time Leonardo Da Vinci painted Mona Lisa, millions of men and women over
the age of 40 were routinely dying of heart attacks; no one talked about how
unusual those early deaths were.
They
needlessly perished because the role of cholesterol in causing atherosclerosis
and heart disease was not recognised then.
It was
not until 1984 that the medical establishment formally recognised the
relationship between high cholesterol and heart attack incidence.
"I
will never forget, as a teenager, seeing a televised debate between two
prominent cardiologists.
"Cardiologist
Dr Pritikin explained how reducing an individual's LDL (bad) cholesterol could
reverse coronary atherosclerosis, whereas the other cardiologist ridiculed the
notion," recalls Prof Dr Sim Kui Hian, president of the National Heart Association
of Malaysia (NHAM).
"I
knew little about heart attacks back then, other than the fact that my family
members and neighbours were having them on a regular basis.
"I
also witnessed the poor diets and lifestyles that these heart attack victims
partook."
Fast
forward to today, the mere mention of cholesterol is sufficient to send
shudders down one's spine and can strike deep fear into the heart of a person.
However,
this is clearly not the case of fear of the unknown.
Various
stakeholders and policymakers have painstakingly and incessantly drummed into
all of us that high cholesterol levels, also known as hypercholesterolaemia,
reflects an unhealthy condition, as it is the chief risk factor for
cardiovascular disease (CVD) - the leading cause of death in Malaysia for the
past three decades, and also accounts for nearly 50 per cent of deaths in both
the developed world and in developing countries.
"Knowledge
is supposedly power, but this seems to be the case of defying gravity!"
laments Prof Sim.
Figures
from the recently concluded 2011 National Health and Morbidity Survey (NHMS)
simply affirm his frustrations.
Malaysians
suffering from hypercholesterolaemia had increased drastically from 20.7 per
cent in 2006 (NHMS III) to 35.1 per cent in 2011; simply put, that is now one
out of three Malaysians.
Prof
Sim explains that perhaps the rising prevalence could be attributed to the fact
that the focus of hypercholesterolaemia has always been on the prevention
aspects or death statistics.
In
other words, there has not been enough information regarding the biochemistry
surrounding how cholesterol works in our system or wreaks havoc in our bodies.
In
conjunction with the NHAM's Annual Scientific Meeting 2012, Fit4Life obtained
an update on the battle against hypercholesterolaemia in an interview with
three cardiologists and key opinion leaders from the association: Prof Sim, Tan
Sri Dr Robaayah Zambahari and Datuk Dr Khoo Kah Lin.
What is cholesterol and how does cholesterol
work in the body?
Prof Sim: The word "cholesterol"
comes from the Greek word chole, meaning "bile", and stereos, meaning
"solid, stiff".
Now,
this calls for my infamous liver-lubricant theory!
Let me
begin with some preliminaries. Well, cholesterol may have a bad rep, but this
waxy-like substance produced by your liver may not necessarily be a deadly
poison; instead, it is an extremely crucial and critical compound needed for
your normal body functioning, i.e. to enable the production of hormones,
Vitamin D and bile acids that aids in the digestion of food in your intestines.
Imagine
cholesterol as being so important that the body has the ability to produce it,
in case we do not get enough of it with food.
Depending
on how much of it we get with food, our body regulates its own production to
keep everything functioning properly.
It is
also your best friend in case you have a stressful lifestyle.
Cholesterol
is the five-star general leading the army when it comes to combating stress.
It is
also important for combating cellular damage, which increases as we age.
Now,
cholesterol acts like a lubricant in your body.
As you
know, oil and water can never mix. However, your body is made up of 70 per cent
water, so then, what happens to the fats or oil that you consume?
In this
case, cholesterol is there to ensure that the fats or oil you eat becomes
soluble or "dissolves" in the water environment of your blood.
Fats
like trans-fat or saturated fat are termed "stubborn fats", as those
are extremely hard on your system to dissolve.
In
turn, your liver has to work overtime to produce more of this lubricant
(cholesterol) to dissolve these types of fats, and this increases the amount of
cholesterol in your bloodstream.
Dr Robaayah: Think of your gifts - gifts are
gifts, but it is the packaging that indicates their difference.
Similarly,
cholesterol is cholesterol, but it is carried in the blood in three different
"packagings" called lipoproteins, which is any compound containing
both lipid (fat) and protein.
You
have the LDL or low-density lipoprotein, HDL or high-density lipoprotein, and
triglycerides.
The
body actually uses the lipoprotein cholesterol as a kind of bandage to cover
abrasions and tears in damaged arterial walls, just as it does for any other
wound.
Can you tell our readers what a healthy
cholesterol level is?
Prof Sim: The definition of a
"healthy" level of cholesterol has been repeatedly adjusted during
the past 30 years.
Cholesterol
can be both good and bad as our individual biochemistry allows for a wide range
of cholesterol levels.
However,
not many know that what is more important than total cholesterol is your
relative quantities of HDL (good) cholesterol in comparison to LDL (bad)
cholesterol.
Essentially,
you need to ensure that your HDL cholesterol levels stay high, and your LDL
cholesterol levels stay low, relative to each other.
Dr Khoo: LDL cholesterol is a major risk
factor for heart disease. As such, it is the main focus of cholesterol-lowering
treatment.
Your
target LDL number can vary, depending on your underlying risk of heart disease.
Most
people should aim for an LDL level below 3.4 mmol/L (130 mg/dL).
If you
have other risk factors for heart disease, your target LDL may be below 2.6
mmol/L (100 mg/dL).
If
you're at very high risk of heart disease, you may need to aim for an LDL level
below 1.8 mmol/L (70 mg/dL). In general, the lower your LDL cholesterol level
is, the better.
We have
National Cholesterol Education, or NCEP, guidelines for where your HDL should
be.
What we
look for in the HDL guidelines - and these are from the American Heart
Association and the American College of Cardiology - is for men to have HDL
above 40, and for women, it should be above 50.
Studies
have shown that for every 1 per cent that you raise your HDL cholesterol,
there's a 2-3 per cent reduction in cardiovascular risk for heart attacks and
strokes.
Say a
50-year-old man's HDL is 36. We get it up to 40, which is about a 10 per cent
increase. That would translate to a 20 per cent reduction in risk.
What should our readers know about high
cholesterol levels (hypercholesterolaemia)?
Prof Sim: Hypercholesterolaemia has become the
dominating health concern of the 21st century.
It is
actually an invented disease that doesn't show up as one.
Even
the healthiest people may have elevated serum cholesterol, and yet their health
remains perfect.
But
they are instantly turned into patients when a routine blood test reveals that
they have a "cholesterol problem".
Symptoms
of high cholesterol do not exist alone in a way a patient or doctor can
identify by touch or sight. That is why the cholesterol issue has confused
millions of people.
Symptoms
of high cholesterol are revealed if you have the symptoms of atherosclerosis, a
common consequence of having high cholesterol levels.
For
instance, the patient may experience leg pain when exercising, due to the
narrowing of the arteries that supply the leg, and/or may exhibit signs of
xanthomas.
In your clinical experience, is there a
particular similarity or trait amongst your pool of patients?
Dr Robaayah: These medical conditions are known
to cause LDL levels to rise.
They
are all conditions which can be controlled medically (with the help of your
doctor, they do not need to be contributory factors):
-
Diabetes
-
Hypertension
-
High
levels of triglycerides
-
Kidney
diseases
-
Liver
diseases
-
Underactive
thyroid gland
The
available data suggests that the correlation between elevated cholesterol and
coronary disease holds true for all ethnic groups, including Asians and eastern
Europeans.
As
people in developing societies attain a more affluent lifestyle and change
their dietary habits accordingly, the incidence of hypercholesterolaemia and
coronary heart disease (CHD) both rise significantly.
The treatment of hypercholesterolaemia has
changed drastically over the years. What sort of intervention do you usually
first recommend?
Dr Robaayah: Based on the National Cholesterol
Education Program (NCEP) and Malaysian Clinical Practice Guidelines (CPG) for
the Treatment of Dyslipidaemia, you're considered to be at a high risk of heart
disease if you have:
-
Diabetes
(now, diabetes is categorised as a "heart disease-risk equivalent",
i.e, the same 10-year CHD risk as people with known CHD)
-
A
previous heart attack/stroke
-
Artery
blockages in your arms or legs (peripheral artery disease)
-
Artery
blockages in your neck (carotid artery disease)
However,
if you happen to have two or more of the following risk factors, that might
also place you in the very high risk group:
-
Smoking
-
Suffering
from hypertension
-
Low
HDL (good) cholesterol
-
Family
history of early heart disease
-
Age
older than 45 if you're a man, or older than 55 if you're a woman
According
to the updated NCEP Adult Treatment Panel (ATP) III endorsed by the National
Heart, Lung, and Blood Institute, the American College of Cardiology, the
American Heart Association, and the Malaysian CPG, the intensity of treatment
for hypercholesterolaemia should be guided by the patient's risk, which depends
on the LDL cholesterol level, the number of CVD risk factors, and whether CVD
is already present.
More
aggressive interventions are recommended for patients at high risk, than for
patients at lower risk.
There
is no logic in waiting for a heart attack to occur before starting statin
therapy.
It is a
proven fact that changes in diet and lifestyle habits alone can only reduce
your LDL cholesterol levels by 20 per cent at most.
Although
the cornerstone of treatment for patients with elevated cholesterol levels will
always be diet and exercise, for most people, statins can be a critical adjunct
therapy for those identified to be at high or medium risk of heart disease.
For
this, statin drugs are best known for their cholesterol-lowering properties,
particularly in LDL cholesterol reduction.
The
notion is simple: high cholesterol levels are associated with heart disease and
stroke. Drugs that lower cholesterol figure to reduce heart disease.
For
statin drugs, this hypothesis has been proved correct - but most clearly for
patients that already have heart disease or are at high risk for heart disease
(see risk classification above).
Simply
put, statins are probably the most important pill a patient with heart disease
can take.
For
these high-risk patients, the secondary prevention effects of statins are
remarkable.
Based
on a post-hoc review of the major statin trials, the NCEP ATP III recently
concluded that in high-risk persons, the recommended LDL cholesterol goal is
less than 100mg/dL, but when risk is very high, an LDL cholesterol goal of less
than 70mg/dL is a therapeutic option.
Dr Khoo: The recommendations of ATP III
should not override a clinician's considered judgment in the management of
individuals.
The
guideline is designed to guide clinical decision-making for most patients, but
not all patients fit the risk assessment.
When
LDL-lowering drug therapy is employed in high risk or moderately high risk
persons, it is advised that intensity of therapy be sufficient to achieve at
least a 30 per cent to 40 per cent reduction in LDL cholesterol levels.
Moreover,
any person at high risk or moderately high risk, who has lifestyle-related risk
factors (e.g. obesity, physical inactivity, elevated triglycerides, low HDL
cholesterol, or metabolic syndrome) is a candidate for Therapeutic Lifestyle
Changes (see TLC works) to modify these risk factors, regardless of LDL
cholesterol level.
If,
after at least six weeks of dietary therapy and exercise, the reduction in LDL
cholesterol levels is inadequate (or if the LDL cholesterol level rises above
the level at which drug therapy is indicated), the addition of drug therapy to
dietary therapy should be considered.
One of the huge cardiology stories in the
past decade has been treatment of elevated cholesterol with 'statin' drugs. Do
they have effects beyond simply lowering cholesterol?
Dr Khoo: Yes, there is a particular statin
(rosuvastatin) which can help slow the progression of atherosclerosis, which is
the build-up of plaque in the artery walls.
Some
statins can even increase HDL cholesterol slightly, especially at the highest
doses.
However,
prescribing a statin might undermine the patient's own efforts in adhering to a
TLC plan. For example, some patients derive a false sense of security that
because they are taking a statin, they can eat whatever they want, and do not
have to exercise.
There has been huge debate over the exact
dose of statins a physician should prescribe to patients. What is your take on
that?
Dr Robaayah: Generally, start at the lowest dose
possible. This is also taking into account the cost factor!
In
Malaysia, treatment for a year with atorvastatin 80mg daily costs RM3,139
(S$1,280), which is one-sixth of the annual Malaysian gross domestic product
per capita of RM18,734.
Thus,
only a small minority can afford this treatment, while the public health system
would be bankrupt if it were to provide high-dose statins for all patients who
might benefit from it.
It does
not mean the higher the statin dose, the likelihood that it will reduce your
cholesterol is greater.
For
instance, at the 10mg dose of rosuvastatin, the average LDL cholesterol
reduction was found to be 46 per cent in one trial.
The
Star/Asia News Network
This
article is supported by Astra Zeneca, in conjunction with the 14th NHAM Annual
Scientific Meeting.
No comments:
Post a Comment